KURA ONCOLOGY, INC. Revenue Breakdown
No Revenue Breakdown for KURA on this site yet.
- 2025-12-31: Others Not split by product in the filing$67.48M100.00%; Total revenue $67.48M.
- 2024-12-31: Others Not split by product in the filing$53.88M100.00%; Total revenue $53.88M.
- 2023-12-31: Total revenue $0.00.
Source checked: the stored Revenue Breakdown page for KURA.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $67.48M 100.00% | $67.48M |
| 2024-12-31 | Not split by product in the filing $53.88M 100.00% | $53.88M |
| 2023-12-31 | $0.00 |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2026-06-30 | Not split by product $20.87M 100.00% | $20.87M |
| 2026-03-31 | Not split by product $18.27M 100.00% | $18.27M |
| 2025-12-31 | Not split by product $17.34M 100.00% | $17.34M |
| 2025-09-30 | Not split by product $20.75M 100.00% | $20.75M |
| 2025-06-30 | Not split by product $15.29M 100.00% | $15.29M |
| 2025-03-31 | Not split by product $14.11M 100.00% | $14.11M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |